Azelaic Acid for Rosacea

Verdict: Effective for papulopustular rosacea

Topical azelaic acid (15% gel) is a well-supported, FDA-approved treatment that reduces the inflammatory papules, pustules, and redness of papulopustular rosacea. It works best on inflammatory lesions and does the least for persistent flushing or visible blood vessels.

A 🔵 A Moderate Evidence Published

🔬Why this grade7-layer evidence engine

This earns a moderate (Tier A) grade because the evidence is consistent across multiple independent, high-quality trials. A systematic review (PMID 16924055; 5 RCTs, 873 people) found azelaic acid cuts inflammatory lesions and erythema as well as or better than metronidazole, and two phase III vehicle-controlled RCTs (PMID 12789172) confirmed the 15% gel beats placebo. A head-to-head RCT (PMID 14623704; n=251) showed it outperformed metronidazole gel, with benefits sustained through 15 weeks.

Larger recent syntheses agree: a 2024 network meta-analysis (PMID 40213532; 19 RCTs, 8,208 people) ranked azelaic acid among the top agents for improving physician-graded severity, and a 2023 review (PMID 37550898; 43 RCTs) again found it superior to vehicle for rosacea. Two of the trials were industry-funded, but their results align with the independent reviews.

Regulators and clinics reinforce this. The FDA approves Finacea 15% gel specifically for the papules and pustules of rosacea, and UK NHS/NICE lists topical azelaic acid as a first-line option; Mayo, Cleveland Clinic, and Harvard concur. The main limit is scope: the strong evidence is for the inflammatory (papulopustular) subtype, not for persistent redness or dilated vessels, which usually need other treatments. It is a prescription medicine, mild local stinging is common early on, and over-the-counter cosmetic versions are lower-strength.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable

Raw score 0.76

← counter-evidence / ineffectiveeffective / strong evidence →

Final grade

A · Published

Confidence

83%

Highly consistent evidence

Evidence level

Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive

L1 ExamineGlobal benchmark

0.50

L3 MechanismPlausibility

0.65

L11 AI re-checkIndependent read

0.80

L2 PubMedPrimary literature

0.85

L5 Clinical bodiesAuthoritative stance

0.85

Against Mixed Supports

▸View the full decision path (audit trail)

compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.76
tier_from_score — 依分數區間映射至 tier letter
apply_hec_rules — 無高階證據可裁決
tier_strict_requirement_check — Tier 條件達標，未降階
detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (5)L2 · primary research & systematic reviews

Azelaic acid in the treatment of papulopustular rosacea: a systematic review of randomized controlled trials

PMID: 16924055 2006 系統性回顧 n = 873

Finding: Azelaic acid 20% cream and 15% gel are effective for papulopustular rosacea, decreasing inflammatory lesion count and erythema; equally effective as or better than metronidazole.

🟢 High quality Academic Effect size: Significant reduction in inflammatory lesions and erythema vs vehicle; >= metronidazole

View on PubMed

The efficacy and safety of minocycline, metronidazole, ivermectin, and azelaic acid in moderate-to-severe papulopustular rosacea: A systematic review and network meta-analysis

PMID: 40213532 2024 Network Meta-analysis n = 8,208

Finding: Network meta-analysis (19 RCTs, 8,208 participants) found azelaic acid 20% yielded among the highest effectiveness in improving IGA score for moderate-to-severe papulopustular rosacea.

🟢 High quality Academic Effect size: Azelaic acid 20% ranked among top agents for IGA improvement

View on PubMed

Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies

PMID: 12789172 2003 RCT (two multicenter, double-blind, vehicle-controlled phase III)

Finding: Both phase III trials demonstrated 15% azelaic acid gel was significantly superior to vehicle, with higher reductions in mean inflammatory lesion count and improvements in erythema; well tolerated.

🟢 High quality ⚠️ Industry-funded Effect size: Statistically significant inflammatory lesion + erythema reduction vs vehicle

View on PubMed

A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial

PMID: 14623704 2003 RCT (multicenter, double-blind, parallel-group) n = 251

Finding: Azelaic acid 15% gel was superior to 0.75% metronidazole gel in reduction of mean nominal lesion count, with sustained improvement through 15 weeks (metronidazole plateaued after week 8).

🟢 High quality ⚠️ Industry-funded Effect size: Greater lesion reduction with azelaic acid vs metronidazole

View on PubMed

A systematic review to evaluate the efficacy of azelaic acid in the management of acne, rosacea, melasma and skin aging

PMID: 37550898 2023 系統性回顧

Finding: Azelaic acid is more effective than vehicle for rosacea; meta-analyses showed improvements in erythema severity and inflammatory lesion counts.

🟢 High quality Effect size: Significant improvement in erythema and inflammatory lesions vs vehicle

View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA

Supportive

Azelex (azelaic acid cream) 20% is indicated for the topical treatment of mild to moderate inflammatory acne vulgaris. Finacea (azelaic acid) Gel, 15% is indicated for topical treatment of inflammatory papules and pustules of mild to moderate rosacea. source↗

L4b EU EFSA

Neutral

Azelaic acid is regulated in the EU as a topical medicinal product for acne and rosacea (e.g. Skinoren, Finacea) and, at lower concentrations, as a cosmetic ingredient; it is not the subject of an EFSA food health claim. source↗

L4c UK NHS

Supportive

Topical azelaic acid is an option for treating acne and for the papules and pustules of rosacea. source↗

L4d TW TFDA / 衛福部

Supportive

壬二酸（azelaic acid）在台灣是處方藥，常見如杜美淨（Skinoren）20% 乳膏，需由皮膚科醫師開立 source↗

L5a NIH Office of Dietary Supplements

Supportive

Azelaic acid comes as a cream, gel, and foam to apply to the skin. It is used to treat the bumps and pimples caused by rosacea... and to treat acne. Azelaic acid is in a class of medications called dicarboxylic acids. source↗

L5b Mayo Clinic

Supportive

L5c Cleveland Clinic

Supportive

L5d Harvard Health

Supportive

L5e Specialty Society (condition-mapped)

Supportive

✓PMID 100% verifiedevery citation checked via NCBI Entrez

🔬5 PubMed studiesindependently re-checked by multiple sub-agents

engine_version: v1.0 claim_id: CLM-COND-rosacea-INT-azelaic-acid-001 繁體中文版 →